DETECTION OF ANTI-GALACTOCEREBROSIDE AUTOANTIBODIES IN HUMAN AFRICAN TRYPANOSOMIASIS

被引:0
|
作者
JAUBERTEAU, MO
BISSER, S
AYED, Z
BRINDEL, I
BOUTEILLE, B
STANGHELLINI, A
GAMPO, S
DOUA, F
BRETON, JC
DUMAS, M
机构
来源
BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE | 1994年 / 87卷 / 5BIS期
关键词
TRYPANOSOMA BRUCEI; HUMAN AFRICAN TRYPANOSOMIASIS; AUTOANTIBODIES; MYELIN; GALACTOCEREBROSIDES; COTE DIVOIRE; CONGO;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The pathogenesis of the central nervous system (CNS) damage in human african trypanosomiasis (HAT) is unknown. In view of an immunological mechanism, as in another trypanosomiasis, Chagas' disease, the causative agent of which is Trypanosoma cruzi, we have searched autoantibodies directed against glycosphingolipids of CNS. Detection and characterization of autoantibodies were performed by ELISA and detection after thin-layer chromatography of glycolipids with sera of an experimental model of HAT in sheep and sera of patients suffering of HAT from Cote d'lvoire and Congo. The predominant reactivity of these,sera, was characterized with galactocerebrosides, the major glycolipids of the myelin. Autoantibodies were defected in 42.8% and 25% of patients' sera, respectively from Cote d'lvoire and Congo. The proportion of these antibodies increased dramatically to 72% in sera of patients with neurological symptoms. Anti-galactocerebroside antibodies were also found in CSF of 24.4% of Congolense patients. The pathogenic significance of these anti-galactocerebroside antibodies remains to be determined. They may constitute a predicative marker for the neurological improvement in HAT.
引用
收藏
页码:333 / 336
页数:4
相关论文
共 50 条
  • [21] New developments in human African trypanosomiasis
    Brun, Reto
    Balmer, Oliver
    CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (05) : 415 - 420
  • [22] Towards the Atlas of human African trypanosomiasis
    Giuliano Cecchi
    Massimo Paone
    José R Franco
    Eric M Fèvre
    Abdoulaye Diarra
    José A Ruiz
    Raffaele C Mattioli
    Pere P Simarro
    International Journal of Health Geographics, 8
  • [23] Treatment perspectives for human African trypanosomiasis
    Bouteille, B
    Oukem, O
    Bisser, S
    Dumas, M
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (02) : 171 - 181
  • [24] A Brief Review of Drug Discovery Research for Human African Trypanosomiasis
    Cullen, Danica R.
    Mocerino, Mauro
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (07) : 701 - 717
  • [25] Phenotypic Drug Discovery for Human African Trypanosomiasis: A Powerful Approach
    Buckner, Frederick S.
    Buchynskyy, Andriy
    Nagendar, Pendem
    Patrick, Donald A.
    Gillespie, J. Robert
    Herbst, Zackary
    Tidwell, Richard R.
    Gelb, Michael H.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2020, 5 (01)
  • [26] Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis
    Andrew Jonathan Nok
    Parasitology Research, 2003, 90 : 71 - 79
  • [27] Therapy of human African trypanosomiasis: Current situation
    Atouguia, J
    Costa, J
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1999, 94 (02): : 221 - 224
  • [28] Emerging trends in the diagnosis of Human African Trypanosomiasis
    Radwanska, Magdalena
    PARASITOLOGY, 2010, 137 (14) : 1977 - 1986
  • [29] Development of novel drugs for human African trypanosomiasis
    Brun, Reto
    Don, Robert
    Jacobs, Robert T.
    Wang, Michael Zhuo
    Barrett, Michael P.
    FUTURE MICROBIOLOGY, 2011, 6 (06) : 677 - 691
  • [30] Novel Therapeutic Targets for Human African Trypanosomiasis
    Shikha Girdhar
    Amit Girdhar
    Viney Lather
    Deepti Pandita
    Current Treatment Options in Infectious Diseases, 2017, 9 (2) : 200 - 209